Kristy L. Pilbeam

Kristy L. Pilbeam

Pediatric Hematology Oncology

217 South Madison Street
Traverse City, MI 49684

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.

A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.

Journal: Pediatric blood & cancer

Published: August 02, 2023

Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report.

Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report.

Journal: Pediatric transplantation

Published: April 27, 2018

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.

Journal: Oncotarget

Published: May 04, 2017

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.

Journal: Molecular cancer therapeutics

Published: September 26, 2016

Showing 1-4 of 4

Last Updated: 09/26/2026